Stock Highlights: Recro Pharma, Inc. (NASDAQ:REPH), GoDaddy Inc. (NYSE:GDDY), U.S. Geothermal Inc. (NYSEMKT:HTM), China Ming Yang Wind Power Group (NYSE:MY), Imperva (NYSE:IMPV)

Brean Capital restated their buy rating on shares of Recro Pharma (NASDAQ:REPH) in a report issued on Monday, Marketbeat reports. Recro Pharma, Inc. (NASDAQ:REPH) belongs to Healthcare sector. Its weekly performance is -6.42%. On last trading day company shares ended up $12.39. Recro Pharma, Inc. (NASDAQ:REPH) distance from 50-day simple moving average (SMA50) is -1.75%.

GoDaddy Inc., (NYSE:GDDY) a public company has reported an increase of 17% in the second quarter results. The company also recorded $394.5 million in the same quarter, rising from $338.5 million in the same quarter last year. GoDaddy Inc. (NYSE:GDDY) shares fell -11.03% in last trading session and ended the day at $26.22. GDDY Gross Margin is 63.30% and its return on assets is -4.10%. GoDaddy Inc. (NYSE:GDDY) quarterly performance is 5.68%.

US Geothermal Inc (NYSEMKT:HTM) said Thursday it could add between 55 MW and 80 MW of annual geothermal capacity thanks to advancing projects at home and in Guatemala.On 06 August, U.S. Geothermal Inc. (NYSEMKT:HTM) shares increased 0.89% and was closed at $0.56. U.S. Geothermal Inc. (NYSEMKT:HTM) year to date (YTD) performance is 22.83%.

China Ming Yang Wind Power Group Limited (NYSE:MY) announced that it has signed a wind turbine purchase agreement with a Chinese state-owned enterprise to provide wind turbines to its wind farm project located in Pakistan with a total capacity of 49.5MW. China Ming Yang Wind Power Group Limited (NYSE:MY) ended the last trading day at $2.80. Company weekly volatility is calculated as 4.26% and price to cash ratio as 2.66. China Ming Yang Wind Power Group Limited (NYSE:MY) showed a weekly performance of 12.45%.

Imperva (NYSE: IMPV) reported Q2 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $53.5 million versus the consensus estimate of $48.55 million. Imperva sees Q3 2015 EPS of $0.05-$0.06, versus the consensus of ($0.16). Imperva sees Q3 2015 revenue of $55-57 million, versus the consensus of $52.40 million. Imperva Inc. (NYSE:IMPV) shares fell -3.70% in last trading session and ended the day at $64.58. IMPV Gross Margin is 77.90% and its return on assets is -25.70%. Imperva Inc. (NYSE:IMPV) quarterly performance is 43.16%.

Leave a Reply

Your email address will not be published. Required fields are marked *